To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden



Status:Archived
Conditions:Alzheimer Disease
Therapuetic Areas:Neurology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:February 2010
End Date:November 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase II, Open Label, Non-Randomized Study of [18F]AZD4694 to Compare PET Measurements of Fibrillar Amyloid Burden Obtained Using Difference Scanning Parameters, Reference Region Procedures and to Assess Test-retest Reliability in Patients With AD & HV


The purpose of this study is to compare PET measurements of fibrillar amyloid burden using
[18F]AZD4694.



We found this trial at
1
site
Clinical Trial Facility in Phoenix Arizona
Phoenix, Arizona
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials